| 标题 |
Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies |
| 网址 | |
| DOI | |
| 其它 |
期刊:Leukemia 作者:Wang Y; Li C; Gale RP; Liang Q; Kay NE; et al 出版日期:2026/07/01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)